125 related articles for article (PubMed ID: 3898978)
1. Platelet sensitivity to prostacyclin in diabetes mellitus.
Pillay PK; Pillay U; Balasubramaniam P; Lee KO
Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
[TBL] [Abstract][Full Text] [Related]
2. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
[TBL] [Abstract][Full Text] [Related]
3. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
[No Abstract] [Full Text] [Related]
4. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
Gisinger C; Schernthaner G
Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
[TBL] [Abstract][Full Text] [Related]
5. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
Akai T; Naka K; Okuda K; Takemura T; Fujii S
Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
[TBL] [Abstract][Full Text] [Related]
6. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
Davis TM; Bown E; Turner RC
Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
[TBL] [Abstract][Full Text] [Related]
7. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
[TBL] [Abstract][Full Text] [Related]
8. Measurement of platelet aggregation in diabetics using the new electronic platelet aggregometer.
Jones RJ; Delamothe AP; Curtis LD; Machin SJ; Betteridge DJ
Diabet Med; 1985 Mar; 2(2):105-9. PubMed ID: 2952392
[TBL] [Abstract][Full Text] [Related]
9. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.
Janka HU; Standl E; Schramm W; Mehnert H
Diabetes; 1983 May; 32 Suppl 2():47-51. PubMed ID: 6086025
[TBL] [Abstract][Full Text] [Related]
10. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
11. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
[TBL] [Abstract][Full Text] [Related]
12. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
[TBL] [Abstract][Full Text] [Related]
13. Human prostacyclin platelet receptors in diabetes mellitus.
Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
[TBL] [Abstract][Full Text] [Related]
14. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
[TBL] [Abstract][Full Text] [Related]
15. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.
Szczeklik A; Gryglewski RJ; Nizankowski R; Musiał J; Pietoń R; Mruk J
Pharmacol Res Commun; 1978 Jun; 10(6):545-56. PubMed ID: 358212
[No Abstract] [Full Text] [Related]
16. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
Katsube N; Sakaguchi K; Fujitani B; Aishita H
Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults.
Varela AF; Runge A; Ignarro LJ; Chaudhuri G
Am J Obstet Gynecol; 1992 Dec; 167(6):1599-604. PubMed ID: 1471673
[TBL] [Abstract][Full Text] [Related]
18. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
Vicari AM; Macagni A; Pozza G
Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
[No Abstract] [Full Text] [Related]
20. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
